Biological characterization of cetuximab-conjugated gold nanoparticles in a tumor animal model

Nanotechnology

Volumn 25, Issue 29, 2014, Pages

  Kao, Hao Wen ^a   Lin, Yi Yu ^a   Chen, Chao Cheng ^a   Chi, Kwan Hwa ^b   Tien, Der Chi ^c   Hsia, Chien Chung ^d   Lin, Wuu Jyh ^d   Chen, Fu Du ^e   Lin, Ming Hsien ^f   Wang, Hsin Ell ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL TAIPEI UNIVERSITY OF TECHNOLOGY   (Taiwan)

^d INSTITUTE OF NUCLEAR ENERGY RESEARCH   (Taiwan)

^e CHINESE CULTURE UNIVERSITY   (Taiwan)

^f TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

cetuximab; epidermal growth factor receptor; gold nanoparticle; radiolabeled; SPECT

Indexed keywords

ANTIBODIES; DRUG DELIVERY; GOLD; MAMMALS; METAL NANOPARTICLES; MOLECULAR BIOLOGY; TUMORS;

CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTORS; GOLD NANOPARTICLES; RADIOLABELED; SPECT;

DIAGNOSIS;

ANTINEOPLASTIC AGENT; CETUXIMAB; GOLD; MONOCLONAL ANTIBODY; NANOCONJUGATE;

ANIMAL; BAGG ALBINO MOUSE; CARCINOMA; CHEMISTRY; DISEASE MODEL; FEMALE; LUNG NEOPLASMS; MICROSPECTROPHOTOMETRY; MOUSE; SURFACE PLASMON RESONANCE; SYNTHESIS; TUMOR CELL CULTURE;

ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; CARCINOMA; DISEASE MODELS, ANIMAL; FEMALE; GOLD; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICROSPECTROPHOTOMETRY; NANOCONJUGATES; SURFACE PLASMON RESONANCE; TUMOR CELLS, CULTURED;

EID: 84903954616     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/25/29/295102     Document Type: Article

References (42)

1. Lewinski N, Colvin V and Drezek R 2008 Cytotoxicity of nanoparticles Small 4 26-49
2. Murphy C J, Gole A M, Stone J W, Sisco P N, Alkilany A M, Goldsmith E C and Baxter S C 2008 Gold nanoparticles in biology: beyond toxicity to cellular imaging Acc. Chem. Res. 41 1721-30
3. Skrabalak S E, Chen J, Sun Y, Lu X, Au L, Cobley C M and Xia Y 2008 Gold nanocages: synthesis, properties, and applications Acc. Chem. Res. 41 1587-95
4. Kim D, Park S, Lee J H, Jeong Y Y and Jon S 2007 Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo x-ray computed tomography imaging J. Am. Chem. Soc. 129 7661-5
5. Eck W, Nicholson A I, Zentgraf H, Semmler W and Bartling S 2010 Anti-CD4-targeted gold nanoparticles induce specific contrast enhancement of peripheral lymph nodes in x-ray computed tomography of live mice Nano Lett. 10 2318-22
6. Prabaharan M, Grailer J J, Pilla S, Steeber D A and Gong S 2009 Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery Biomaterials 30 6065-75
7. Li D, He Q and Li J 2009 Smart core/shell nanocomposites: intelligent polymers modified gold nanoparticles Adv. Colloid Interface Sci. 149 28-38
8. Li D, Li C, Yang Y, He Q and Li J 2011 Interfacial dispersion of poly(N-isopropylacrylamide)/ gold nanocomposites J. Nanosci. Nanotechnol. 11 2052-6
9. Glazer E S, Zhu C, Massey K L, Thompson C S, Kaluarachchi W D, Hamir A N and Curley S A 2010 Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles Clin. Cancer Res. 16 5712-21
10. Ma M, Chen H, Chen Y, Wang X, Chen F, Cui X and Shi J 2012 Au capped magnetic core/mesoporous silica shell nanoparticles for combined photothermo-/chemo-therapy and multimodal imaging Biomaterials 33 989-98
11. Lim Z Z, Li J E, Ng C T, Yung L Y and Bay B H 2011 Gold nanoparticles in cancer therapy Acta Pharmacol. Sin. 32 983-90
12. Hakkinen H 2012 The gold-sulfur interface at the nanoscale Nat. Chem. 4 443-55
13. Waksal H W 1999 Role of an anti-epidermal growth factor receptor in treating cancer Cancer Metastasis Rev. 18 427-36
14. Citri A and Yarden Y 2006 EGF-ERBB signalling: towards the systems level Nat. Rev. Mol. Cell Biol. 7 505-16
15. Sharma S V, Bell D W, Settleman J and Haber D A 2007 Epidermal growth factor receptor mutations in lung cancer Nat. Rev. Cancer 7 169-81
16. Sharafinski M E, Ferris R L, Ferrone S and Grandis J R 2010 Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck Head Neck 32 1412-21
17. Zeineldin R, Muller C Y, Stack M S and Hudson L G 2010 Targeting the EGF receptor for ovarian cancer therapy J. Oncol. 2010 414676
18. Graham J, Muhsin M and Kirkpatrick P 2004 Cetuximab Nat. Rev. Drug. Discov. 3 549-50
19. Lin Y Y, Li J J, Chang C H, Lu Y C, Hwang J J, Tseng Y L, Lin W J, Ting G and Wang H E 2009 Evaluation of pharmacokinetics of 111In-labeled VNB-PEGylated liposomes after intraperitoneal and intravenous administration in a tumor/ascites mouse model Cancer Biother Radiopharm 24 453-60
20. Lin Y Y, Kao H W, Li J J, Hwang J J, Tseng Y L, Lin W J, Lin M H, Ting G and Wang H E 2013 Tumor burden talks in cancer treatment with PEGylated liposomal drugs PLoS One 8 e63078
21. Frens G 1973 Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions Nature 241 20-2
22. Kao H W, Lin Y Y, Chen C C, Chi K H, Tien D C, Hsia C C, Lin M H and Wang H E 2013 Evaluation of EGFR-targeted radioimmuno-gold-nanoparticles as a theranostic agent in a tumor animal model Bioorg. Med. Chem. Lett. 23 3180-5
23. Wang H E, Yu H M, Liu R S, Lin M, Gelovani J G, Hwang J J, Wei H J and Deng W P 2006 Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer J. Nucl. Med. 47 1161-71
24. Zhang G, Yang Z, Lu W, Zhang R, Huang Q, Tian M, Li L, Liang D and Li C 2009 Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice Biomaterials 30 1928-36
25. Puri N and Salgia R 2008 Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer J. Carcinog 7 9
26. Jaramillo M L, Banville M, Collins C, Paul-Roc B, Bourget L and O'Connor-McCourt M 2008 Differential sensitivity of A549 non-small lung carcinoma cell responses to epidermal growth factor receptor pathway inhibitors Cancer Biol. Ther. 7 557-68
27. Hu M, Scollard D, Chan C, Chen P, Vallis K and Reilly R M 2007 Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [111In]DTPA-hEGF Nucl. Med. Biol. 34 887-96
28. Reilly R M and Gariepy J 1998 Factors influencing the sensitivity of tumor imaging with a receptor-binding radiopharmaceutical J. Nucl. Med. 39 1036-43
29. Chithrani B D, Ghazani A A and Chan W C 2006 Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells Nano Lett. 6 662-8
30. Mould D R and Sweeney K R 2007 The pharmacokinetics and pharmacodynamics of monoclonal antibodies - mechanistic modeling applied to drug development Curr. Opin. Drug. Discov. Devel. 10 84-96
31. Robert F et al 2001 Phase I study of anti - epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer J. Clin. Oncol. 19 3234-43
32. Baselga J et al 2000 Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin J. Clin. Oncol. 18 904-14
33. Thariat J, Azzopardi N, Peyrade F, Launay-Vacher V, Santini J, Lecomte T, Etienne-Grimaldi M C, Paintaud G and Milano G 2008 Cetuximab pharmacokinetics in end-stage kidney disease under hemodialysis J. Clin. Oncol. 26 4223-5
34. Lu W, Zhang G, Zhang R, Flores L G 2nd, Huang Q, Gelovani J G and Li C 2010 Tumor site-specific silencing of NF-kappaB p65 by targeted hollow gold nanosphere-mediated photothermal transfection Cancer Res. 70 3177-88
35. Hillyer J F and Albrecht R M 2001 Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles J. Pharm. Sci. 90 1927-36
36. Bruhns P 2012 Properties of mouse and human IgG receptors and their contribution to disease models Blood 119 5640-9
37. Mizoguchi Y, Tanimoto K, Yue C L and Horiuchi Y 1979 Immune receptors (IgG-Fc and complement receptors) in normal human organs Lab. Invest. 40 703-7
38. Fan J, Bi L, Wu T, Cao L, Wang D, Nan K, Chen J, Jin D, Jiang S and Pei G 2012 A combined chitosan/nano-size hydroxyapatite system for the controlled release of icariin J. Mater. Sci. Mater. Med. 23 399-407
39. Ishida O, Maruyama K, Tanahashi H, Iwatsuru M, Sasaki K, Eriguchi M and Yanagie H 2001 Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo Pharm. Res. 18 1042-8
40. Kirpotin D B, Drummond D C, Shao Y, Shalaby M R, Hong K, Nielsen U B, Marks J D, Benz C C and Park J W 2006 Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models Cancer Res. 66 6732-40
41. Mamot C, Drummond D C, Noble C O, Kallab V, Guo Z, Hong K, Kirpotin D B and Park J W 2005 Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo Cancer Res. 65 11631-8
42. Chattopadhyay N, Fonge H, Cai Z, Scollard D, Lechtman E, Done S J, Pignol J P and Reilly R M 2012 Role of antibody-mediated tumor targeting and route of administration in nanoparticle tumor accumulation in vivo Mol. Pharm. 9 2168-79